Nedal Safwat's most recent trade in Accelerate Diagnostics Inc was a trade of 100,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 17, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Accelerate Diagnostics Inc | Nedal Safwat | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2020 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
Accelerate Diagnostics Inc | Nedal Safwat | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2020 | 39,769 | 139,769 | - | - | Employee Stock Option (right to buy) | |
Accelerate Diagnostics Inc | Nedal Safwat | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2020 | 30,000 | 30,000 | - | - | Employee Restricted Stock Units |